Zaks I - Search Results

1

Activators of AMPK: not just for type II diabetes.

Zaks I, Getter T, Gruzman A. Zaks I, et al. Future Med Chem. 2014 Jul;6(11):1325-53. doi: 10.4155/fmc.14.74. Future Med Chem. 2014. PMID: 25163002 Review.

2

A chemical chaperone-based drug candidate is effective in a mouse model of amyotrophic lateral sclerosis (ALS).

Getter T, Zaks I, Barhum Y, Ben-Zur T, Böselt S, Gregoire S, Viskind O, Shani T, Gottlieb H, Green O, Shubely M, Senderowitz H, Israelson A, Kwon I, Petri S, Offen D, Gruzman A. Getter T, et al. Among authors: zaks i. ChemMedChem. 2015 May;10(5):850-61. doi: 10.1002/cmdc.201500045. Epub 2015 Mar 13. ChemMedChem. 2015. PMID: 25772747

3

Study protocol: A multimethod psychophysiological randomized controlled trial of a couple therapy for post-traumatic stress disorder.

Zaks I, Dekel R, Zuckerman YS, Horesh D. Zaks I, et al. Contemp Clin Trials. 2023 Sep;132:107280. doi: 10.1016/j.cct.2023.107280. Epub 2023 Jul 5. Contemp Clin Trials. 2023. PMID: 37419309

4

THC degradation does not impair the accuracy of THC doses aerosolized by the metered-dose SyqeAir inhaler: a 24-month stability trial.

Aviram J, Atzmony D, Frenklakh A, Kroll A, Zaks I, Hazekamp A. Aviram J, et al. Among authors: zaks i. J Cannabis Res. 2022 Oct 24;4(1):55. doi: 10.1186/s42238-022-00166-5. J Cannabis Res. 2022. PMID: 36274184 Free PMC article.

5

[Serum albumin: properties and functions and their evaluation in emergencies].

Gryzunov IuA, Zaks IO, Moroz VV, Dobretsov GE, Komarova MN, Meshcheriakov GN. Gryzunov IuA, et al. Among authors: zaks io. Anesteziol Reanimatol. 2004 Nov-Dec;(6):68-74. Anesteziol Reanimatol. 2004. PMID: 15717526 Russian. No abstract available.

6

[Dynamics of prekallikrein and kallikrein inhibitors in development of acute pulmonary lesion (experimental study)].

Meshcheriakov GN, Ostapchenko DA, Zaks IO, Vlasenko AV. Meshcheriakov GN, et al. Among authors: zaks io. Anesteziol Reanimatol. 2003 Nov-Dec;(6):47-9. Anesteziol Reanimatol. 2003. PMID: 14991981 Russian.

7

[Use of orthostasis during artificial pulmonary ventilation in patients with acute parenchymal pulmonary lesion].

Vlasenko AV, Ostapchenko DA, Zaks IO, Mitrokhin AA, Galushka SV. Vlasenko AV, et al. Among authors: zaks io. Anesteziol Reanimatol. 2003 Nov-Dec;(6):38-44. Anesteziol Reanimatol. 2003. PMID: 14991979 Clinical Trial. Russian.

8

[Liquid pulmonary ventilation, its possibilities and prospects (current state of the question)].

Moroz VV, Vlasenko AV, Zaks IO. Moroz VV, et al. Among authors: zaks io. Anesteziol Reanimatol. 2001 May-Jun;(6):66-73. Anesteziol Reanimatol. 2001. PMID: 11855070 Review. Russian. No abstract available.

9

[The need and outlook for alkalizing therapy in cardiopulmonary resuscitation].

Moroz VV, Zaks IO, Lobus TV, Volkova MI. Moroz VV, et al. Among authors: zaks io. Anesteziol Reanimatol. 2000 Mar-Apr;(2):63-7. Anesteziol Reanimatol. 2000. PMID: 10833841 Review. Russian. No abstract available.

10

[Bio-impedancemetry in the assessment of aqueous sectors of the body].

Ivanov GG, Meshcheriakov GN, Kravchenko NR, Zaks IO, Moroz VV, Nikolaev DV, Arapova OA. Ivanov GG, et al. Among authors: zaks io. Anesteziol Reanimatol. 1999 Jan-Feb;(1):59-63. Anesteziol Reanimatol. 1999. PMID: 10199052 Review. Russian. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page